Form 4 for ATRC AtriCure, Inc.
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001323885-23-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-03 | 2023-05-01 | ATRC | Dahlquist Karl S. | CLO | S - Sale | $44.83 | -4,417 | 36.3K | -11% | -$198.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | S | D | 4,417 | $44.83 | 36,319 | D | — | — | (F1) These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023. (F2) This transaction was executed in multiple trades at prices ranging from $44.31 to $45.45 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |